Sign in
Taking peopleNo phase

Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.

Key facts

Who runs it
Hospital Clinic of Barcelona
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
48 people, planned
Started
1 Mar 2023
Planned end
20 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Extracorporeal support with haemoperfusion
  • Conventional treatment
Record updated
10 June 2025

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Patients with a sepsis diagnosis, according to the diagnostic criteria of the International Sepsis-3 Consensus Conference, and without response to the treatment of septic shock who meet the following conditions:
  • Sepsis of abdominal origin with controlled infectious focus
  • Noradrenaline dose> 0.5 µg / kg / min to maintain adequate organ perfusion after optimization of fluid therapy
  • Dysfunction of two or more organs with SOFA ≥ 9 (5)
  • Blood lactate ≥ 2 mmol / L
  • Procalcitonin (PCT)> 10 ng / mL
  • CRP> 100 mg / L
  • IL-6> 2000 pg / ml

Who cannot take part

  • Severe coagulopathy with high risk of bleeding
  • Age under 18 years or over 80 years
  • Pregnancy or breastfeeding
  • Terminally ill patients or with a life expectancy of less than 48 hours
  • Thrombocytopenia <60,000 / mm3
  • Pancytopenia
  • Inclusion in another research protocol
  • In case of re-entry during the study period, only the first admission will be included
  • Use of another haemoperfusion device

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial is currently available in Spain.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Low-level interventional clinical trial to evaluate the effectiveness and safety of extracorporeal support with hemoperfusion in critical patients with septic multiorgan dysfunction syndrome.

The 2 groups in the trial

  • Conventional treatmentExisting treatment, for comparison

    Patients receiving conventional treatment for multiorganic dysfunction syndrome from septic origin.

  • Extracorporeal support with haemoperfusion treatmentTreatment being tested

    Patients receiving extracorporeal support with haemoperfusion for multiorganic dysfunction syndrome from septic origin.

    Treatment: Extracorporeal support with haemoperfusion

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Impact of Hemoperfusion With a Neutral Macroporous Resin Cartridge as Adjunctive Treatment in Septic Patients With Multiorgan Dysfunction Syndrome (MODS) Admitted to Intensive Care Units.
Criteria questions
Built from NCT05044403, who can take part
Record updated
10 June 2025